Hi there!
We track 70,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!

Asimov provides scientists and manufacturers tools that simplify designing and manufacturing biologic drugs and gene therapies. The company combines mammalian synthetic biology with computer-aided…

Asimov provides scientists and manufacturers tools that simplify designing and manufacturing biologic drugs and gene therapies. The company combines mammalian synthetic biology with computer-aided…
Headquarters & focus: Boston-based synthetic biology company building CAD-style platform for biologic, cell, gene, and RNA therapeutic design
Product: Integrated platform of engineered host cell lines, validated genetic parts, and cloud-based design software (CHO Edge, LV Edge, AAV Edge, RNA Edge)
Founding: Founded in 2017 by Alec Nielsen, Christopher Voigt, Douglas Densmore, and Raja Srinivas
Funding: Reported total funding approximately $205M, including a reported $200M round announced Jan 2023
Employees: Approximately 106 employees
Design and manufacturing tooling for next-generation biologics, cell, gene, and RNA therapies.
2017
Biotechnology Research
4700000
Reported seed financing at company launch
200000000
Reported large institutional financing announced Jan 2023
“AME Cloud Ventures, Andreessen Horowitz, CPP Investments, Casdin Capital, DCVC, Fidelity, Horizons Ventures, KdT Ventures, Pillar VC”
Your next opportunity is in here somewhere. Sign up to explore 70,000+ startups and their open roles. No spam. No gamification. Just jobs.
70,000+
Startups
81,000+
Open Roles
4,600+
New This Week
| Company |
|---|